Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · IEX Real-Time Price · USD
16.52
+0.73 (4.62%)
At close: Mar 28, 2024, 4:00 PM
16.82
+0.30 (1.82%)
After-hours: Mar 28, 2024, 6:02 PM EDT

DAWN Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current2023202220212020
Market Capitalization
1,4441,2711,5831,044-
Market Cap Growth
--19.71%51.68%--
Enterprise Value
1,0789051,241759-43
PE Ratio
-6.73-6.73-11.13-6.11-
PB Ratio
4.173.674.773.71-
P/FCF Ratio
-8.64-8.64-14.40-21.50-
P/OCF Ratio
-8.65-8.65-14.41-21.50-
EV/EBITDA Ratio
-4.80-4.80-8.76-4.461.07
EV/EBIT Ratio
-4.79-4.79-8.73-4.451.07
EV/FCF Ratio
-6.15-6.15-11.30-15.653.19
Debt / Equity Ratio
0.000.000.000.00-0.01
Debt / EBITDA Ratio
0.000.00-0.010.00-0.01
Debt / FCF Ratio
0.000.00-0.010.00-0.03
Quick Ratio
12.4212.4220.6032.8421.91
Current Ratio
12.7212.7220.9433.4322.58
Interest Coverage
-----1349.23
Return on Equity (ROE)
-51.70%-51.70%-42.30%-83.10%124.90%
Return on Assets (ROA)
-48.30%-48.30%-40.50%-63.70%-111.00%
Return on Capital (ROIC)
-59.39%-59.39%-44.14%-25.85%25.62%
Earnings Yield
-13.09%-14.87%-8.98%-16.35%-
FCF Yield
-10.19%-11.57%-6.94%-4.65%-
Buyback Yield / Dilution
-21.85%-21.85%-77.13%-568.42%6.67%
Total Shareholder Return
-21.85%-21.85%-77.13%-568.42%6.67%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).